545 related articles for article (PubMed ID: 23689704)
1. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients.
Kapoor K; Jajoo M; Dublish S; Dabas V; Gupta S; Manchanda V
Pediatr Crit Care Med; 2013 Jul; 14(6):e268-72. PubMed ID: 23689704
[TBL] [Abstract][Full Text] [Related]
2. The use of colistin in critically ill children in a pediatric intensive care unit.
Karbuz A; Özdemir H; Yaman A; Kocabaş BA; Odek Ç; Güriz H; Aysev AD; Çiftçi E; Kendirli T; Ateş C; İnce E
Pediatr Infect Dis J; 2014 Jan; 33(1):e19-24. PubMed ID: 24346607
[TBL] [Abstract][Full Text] [Related]
3. Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.
Falagas ME; Sideri G; Vouloumanou EK; Papadatos JH; Kafetzis DA
Pediatr Infect Dis J; 2009 Feb; 28(2):123-7. PubMed ID: 19116601
[TBL] [Abstract][Full Text] [Related]
4. Intravenous colistin administration in neonates.
Jajoo M; Kumar V; Jain M; Kumari S; Manchanda V
Pediatr Infect Dis J; 2011 Mar; 30(3):218-21. PubMed ID: 21245777
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study on the effects of colistin therapy in children with multidrug-resistant Gram-negative bacterial pathogens: impact of HIV status on outcome.
Dimitriades K; Morrow BM; Jeena P
Arch Dis Child; 2014 Mar; 99(3):262-6. PubMed ID: 24170687
[TBL] [Abstract][Full Text] [Related]
6. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
Huang J; Tang YQ; Sun JY
Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
[TBL] [Abstract][Full Text] [Related]
7. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
[TBL] [Abstract][Full Text] [Related]
8. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
[TBL] [Abstract][Full Text] [Related]
9. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
[TBL] [Abstract][Full Text] [Related]
10. Old agent, new experience: colistin use in the paediatric Intensive Care Unit--a multicentre study.
Paksu MS; Paksu S; Karadag A; Sensoy G; Asilioglu N; Yildizdas D; Akyildiz BN; Kendirli T; Demirkol D; Akgun M; Alp E; Ciftci E; Guney AK; Murat N
Int J Antimicrob Agents; 2012 Aug; 40(2):140-4. PubMed ID: 22727770
[TBL] [Abstract][Full Text] [Related]
11. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
[TBL] [Abstract][Full Text] [Related]
13. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.
Falagas ME; Rafailidis PI; Ioannidou E; Alexiou VG; Matthaiou DK; Karageorgopoulos DE; Kapaskelis A; Nikita D; Michalopoulos A
Int J Antimicrob Agents; 2010 Feb; 35(2):194-9. PubMed ID: 20006471
[TBL] [Abstract][Full Text] [Related]
14. Colistin and polymyxin B in critical care.
Michalopoulos A; Falagas ME
Crit Care Clin; 2008 Apr; 24(2):377-91, x. PubMed ID: 18361952
[TBL] [Abstract][Full Text] [Related]
15. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.
Michalopoulos AS; Tsiodras S; Rellos K; Mentzelopoulos S; Falagas ME
Clin Microbiol Infect; 2005 Feb; 11(2):115-21. PubMed ID: 15679485
[TBL] [Abstract][Full Text] [Related]
16. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.
Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC
Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic evaluation of colistin sodium.
Michalopoulos AS; Karatza DC; Gregorakos L
Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):245-55. PubMed ID: 21128824
[TBL] [Abstract][Full Text] [Related]
19. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU.
Kallel H; Bahloul M; Hergafi L; Akrout M; Ketata W; Chelly H; Hamida CB; Rekik N; Hammami A; Bouaziz M
Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093
[TBL] [Abstract][Full Text] [Related]
20. Colistin administration to pediatric and neonatal patients.
Iosifidis E; Antachopoulos C; Ioannidou M; Mitroudi M; Sdougka M; Drossou-Agakidou V; Tsivitanidou M; Roilides E
Eur J Pediatr; 2010 Jul; 169(7):867-74. PubMed ID: 20119725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]